Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant/advanced fibrosis in patients with nonalcoholic fatty liver disease

Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography

(2018) Eugenia Tsai et al.   Clinics in Liver Disease

Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration

(2018) Yuval A. Patel et al.   DIGESTIVE DISEASES AND SCIENCES

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

(2018) Zobair M. Younossi et al.   HEPATOLOGY

The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study

(2018) Hiroshi Ishiba et al.   JOURNAL OF GASTROENTEROLOGY

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers

(2018) Eduardo Vilar-Gomez et al.   JOURNAL OF HEPATOLOGY

Determinants of fibrosis progression and regression in NASH

(2018) Detlef Schuppan et al.   JOURNAL OF HEPATOLOGY

Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD

(2018) Elliot B. Tapper et al.   Nature Reviews Gastroenterology & Hepatology

Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

(2018) Vincent Wai-Sun Wong et al.   Nature Reviews Gastroenterology & Hepatology

Validation of Serum Test for Advanced Liver Fibrosis in Patients with Nonalcoholic Steatohepatitis

(2018) Rohit Loomba et al.   Clinical Gastroenterology and Hepatology

Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort

(2018) Stergios Polyzos et al.   HORMONE AND METABOLIC RESEARCH

Advanced Liver Fibrosis Is Independently Associated with Palmitic Acid and Insulin Levels in Patients with Non-Alcoholic Fatty Liver Disease

(2018) Kátia Cansanção et al.   Nutrients

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods

(2017) Masato Yoneda et al.   JOURNAL OF GASTROENTEROLOGY

Growth differentiation factor 15 predicts advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease

(2017) Bo Kyung Koo et al.   LIVER INTERNATIONAL

Use of Liver Imaging and Biopsy in Clinical Practice

(2017) Elliot B. Tapper et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease

(2016) Elliot B Tapper et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy

(2016) Christophe Cassinotto et al.   HEPATOLOGY

Serum complement C3 levels are associated with nonalcoholic fatty liver disease independently of metabolic features in Chinese population

(2016) Chengfu Xu et al.   Scientific Reports

Proteomic Analysis of Non-depleted Serum Proteins from Bottlenose Dolphins Uncovers a High Vanin-1 Phenotype

(2016) Philip Sobolesky et al.   Scientific Reports

Nonalcoholic Fatty Liver Disease

(2015) Mary E. Rinella   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Nonalcoholic fatty liver disease

(2015) Elizabeth M. Brunt et al.   Nature Reviews Disease Primers

Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study

(2014) Rohit Loomba et al.   HEPATOLOGY

Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease

(2014) Masanori Abe et al.   JOURNAL OF GASTROENTEROLOGY

Serum Complement C3f and Fibrinopeptide A Are Potential Novel Diagnostic Biomarkers for Non-Alcoholic Fatty Liver Disease: A Study in Qingdao Twins

(2014) Yong-Ning Xin et al.   PLoS One

Complement Alternative Pathway Activation in Human Nonalcoholic Steatohepatitis

(2014) Filip M. Segers et al.   PLoS One

Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease

(2013) Katsutoshi Tokushige et al.   JOURNAL OF GASTROENTEROLOGY

Immunodepletion Plasma Proteomics by TripleTOF 5600 and Orbitrap Elite/LTQ-Orbitrap Velos/Q Exactive Mass Spectrometers

(2013) Kelly A. Jones et al.   JOURNAL OF PROTEOME RESEARCH

Glycemic Variability Is an Independent Predictive Factor for Development of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease

(2013) Motoi Hashiba et al.   PLoS One

Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography

(2013) Donghee Kim et al.   RADIOLOGY

The role of the complement system in metabolic organs and metabolic diseases

(2013) Julia Phieler et al.   SEMINARS IN IMMUNOLOGY

Comparison of triple quadrupole and high-resolution TOF-MS for quantification of peptides

(2012) Lieve Dillen et al.   Bioanalysis

Performance Characteristics of a New Hybrid Quadrupole Time-of-Flight Tandem Mass Spectrometer (TripleTOF 5600)

(2011) Genna L. Andrews et al.   ANALYTICAL CHEMISTRY

Platelet count for predicting fibrosis in nonalcoholic fatty liver disease

(2011) Masato Yoneda et al.   JOURNAL OF GASTROENTEROLOGY

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology

Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease

(2009) Lauren N. Bell et al.   HEPATOLOGY

Activation of the complement system in human nonalcoholic fatty liver disease

(2009) Sander S. Rensen et al.   HEPATOLOGY